(R)-(+)-1-Butyn-3-ol | CAS:42969-65-3

We serve (R)-(+)-1-Butyn-3-ol CAS:42969-65-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(R)-(+)-1-Butyn-3-ol

Chemical Name:(R)-(+)-1-Butyn-3-ol
CAS.NO:42969-65-3
Synonyms:(R)-(+)-1-Butyn-3-ol
(2R)-but-3-yn-2-ol
(R)-(+)-3-Butyn-2-ol
 
Physical and Chemical Properties:
Density 0.89
Boiling Point 108-111 ºC
Molecular Formula C4H6O
Molecular Weight 70.090
Flash Point 10 ºC
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Vorapaxar Sulfate(CAS:705260-08-8).



Contact us for information like (R)-(+)-1-Butyn-3-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(R)-(+)-3-Butyn-2-ol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(R)-(+)-1-Butyn-3-ol Use and application,(R)-(+)-3-Butyn-2-ol technical grade,usp/ep/jp grade.


Related News: Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.3-FLUOROPHENYL ISOTHIOCYANATE manufacturer Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.4-[2-(1-Pipiridine)ethoxybenzoic acid hydrochloride supplier Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.1-Chlorooctadecane vendor Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.The first is the API – which is the central ingredient.